Current through Register Vol. 56, No. 24, December 18, 2024
Section 8:57A-1.7 - Clinical laboratory reporting(a) The director of every clinical laboratory shall report electronically to the Department the results of examinations of tissue specimens and/or hematology examinations that are positive for the existence of cancer or other specified tumorous and precancerous disease using the HL-7 standard protocol set forth in the NAACCR Standards for Cancer Registries Volume V: Pathology Laboratory Electronic Reporting or the NAACCR Data Standards for Cancer Registries--Data Standards and Data Dictionary (Volume II--Version 16), which includes all available patient identifying information, the tissue examined, and the results of the pathologic examination, and the name, address and/or telephone number of the referring physician.(b) A clinical laboratory that fails to report cases of cancer or other specified tumorous and precancerous diseases shall be liable for a penalty of up to $ 500.00 per unreported case.N.J. Admin. Code § 8:57A-1.7
Amended by 50 N.J.R. 1893(a), effective 8/20/2018